Acute-phase proteins and other systemic responses to inflammation C Gabay, I Kushner New England journal of medicine 340 (6), 448-454, 1999 | 8997 | 1999 |
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update JS Smolen, R Landewé, J Bijlsma, G Burmester, K Chatzidionysiou, ... Annals of the rheumatic diseases 76 (6), 960-977, 2017 | 3117 | 2017 |
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs JS Smolen, R Landewé, FC Breedveld, M Dougados, P Emery, ... Annals of the rheumatic diseases 69 (6), 964-975, 2010 | 2407 | 2010 |
Interleukin-6 and chronic inflammation C Gabay Arthritis research & therapy 8, 1-6, 2006 | 1927 | 2006 |
Interleukin-1 receptor antagonist: role in biology WP Arend, M Malyak, CJ Guthridge, C Gabay Annual review of immunology 16 (1), 27-55, 1998 | 1425 | 1998 |
IL‐1, IL‐18, and IL‐33 families of cytokines WP Arend, G Palmer, C Gabay Immunological reviews 223 (1), 20-38, 2008 | 1102 | 2008 |
IL-1 pathways in inflammation and human diseases C Gabay, C Lamacchia, G Palmer Nature Reviews Rheumatology 6 (4), 232-241, 2010 | 1046 | 2010 |
Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial C Gabay, P Emery, R Van Vollenhoven, A Dikranian, R Alten, K Pavelka, ... The Lancet 381 (9877), 1541-1550, 2013 | 829 | 2013 |
The interleukin (IL)-1 cytokine family–Balance between agonists and antagonists in inflammatory diseases J Palomo, D Dietrich, P Martin, G Palmer, C Gabay Cytokine 76 (1), 25-37, 2015 | 525 | 2015 |
EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis DM Gerlag, K Raza, LGM Van Baarsen, E Brouwer, CD Buckley, ... Annals of the rheumatic diseases 71 (5), 638-641, 2012 | 519 | 2012 |
Interleukin 1 receptor antagonist (IL-1Ra) is an acute-phase protein. C Gabay, MF Smith, D Eidlen, WP Arend The Journal of clinical investigation 99 (12), 2930-2940, 1997 | 441 | 1997 |
Leptin signaling deficiency impairs humoral and cellular immune responses and attenuates experimental arthritis N Busso, A So, V Chobaz-Péclat, C Morard, E Martinez-Soria, ... The Journal of Immunology 168 (2), 875-882, 2002 | 434 | 2002 |
Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells D Moulin, O Donzé, D Talabot-Ayer, F Mézin, G Palmer, C Gabay Cytokine 40 (3), 216-225, 2007 | 404 | 2007 |
Leptin deficiency enhances sensitivity to endotoxin-induced lethality R Faggioni, G Fantuzzi, C Gabay, A Moser, CA Dinarello, KR Feingold, ... American Journal of Physiology-Regulatory, Integrative and Comparative …, 1999 | 403 | 1999 |
Inhibition of interleukin‐33 signaling attenuates the severity of experimental arthritis G Palmer, D Talabot‐Ayer, C Lamacchia, D Toy, CA Seemayer, S Viatte, ... Arthritis & rheumatism: official journal of the American College of …, 2009 | 401 | 2009 |
Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics G Dennis, CTJ Holweg, SK Kummerfeld, DF Choy, AF Setiadi, ... Arthritis research & therapy 16, 1-18, 2014 | 377 | 2014 |
IL-1 receptor antagonist serum levels are increased in human obesity: a possible link to the resistance to leptin? CA Meier, E Bobbioni, C Gabay, F Assimacopoulos-Jeannet, A Golay, ... The Journal of Clinical Endocrinology & Metabolism 87 (3), 1184-1188, 2002 | 375 | 2002 |
IL-36R ligands are potent regulators of dendritic and T cells S Vigne, G Palmer, C Lamacchia, P Martin, D Talabot-Ayer, E Rodriguez, ... Blood, The Journal of the American Society of Hematology 118 (22), 5813-5823, 2011 | 372 | 2011 |
CD14 is an acute-phase protein S Bas, BR Gauthier, U Spenato, S Stingelin, C Gabay The Journal of Immunology 172 (7), 4470-4479, 2004 | 353 | 2004 |
Interleukin-33 is biologically active independently of caspase-1 cleavage D Talabot-Ayer, C Lamacchia, C Gabay, G Palmer Journal of Biological Chemistry 284 (29), 19420-19426, 2009 | 335 | 2009 |